BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 29956075)

  • 21. Incidence of invasive fungal infection in acute lymphoblastic and acute myelogenous leukemia in the era of antimold prophylaxis.
    Oh SM; Byun JM; Chang E; Kang CK; Shin DY; Koh Y; Hong J; Kim TS; Choe PG; Park WB; Kim NJ; Yoon SS; Kim I; Oh MD
    Sci Rep; 2021 Nov; 11(1):22160. PubMed ID: 34773060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiology of invasive fungal infections during induction therapy in adults with acute lymphoblastic leukemia: a GRAALL-2005 study.
    Mariette C; Tavernier E; Hocquet D; Huynh A; Isnard F; Legrand F; Lhéritier V; Raffoux E; Dombret H; Ifrah N; Cahn JY; Thiébaut A
    Leuk Lymphoma; 2017 Mar; 58(3):586-593. PubMed ID: 27397551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral voriconazole versus intravenous low dose amphotericin B for primary antifungal prophylaxis in pediatric acute leukemia induction: a prospective, randomized, clinical study.
    Mandhaniya S; Swaroop C; Thulkar S; Vishnubhatla S; Kabra SK; Xess I; Bakhshi S
    J Pediatr Hematol Oncol; 2011 Dec; 33(8):e333-41. PubMed ID: 22042283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Invasive fungal infections amongst patients with acute-on-chronic liver failure at high risk for fungal infections.
    Verma N; Singh S; Taneja S; Duseja A; Singh V; Dhiman RK; Chakrabarti A; Chawla YK
    Liver Int; 2019 Mar; 39(3):503-513. PubMed ID: 30276951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Invasive fungal infection following chemotherapy for acute myeloid leukaemia-Experience from a developing country.
    Korula A; Abraham A; Abubacker FN; Viswabandya A; Lakshmi KM; Abraham OC; Rupali P; Varghese GM; Michael JS; Srivastava A; Mathews V; George B
    Mycoses; 2017 Oct; 60(10):686-691. PubMed ID: 28736936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breakthrough Invasive Fungal Infections in Patients with Acute Myeloid Leukemia.
    Wasylyshyn A; Linder KA; Castillo CG; Zhou S; Kauffman CA; Miceli MH
    Mycopathologia; 2020 Apr; 185(2):299-306. PubMed ID: 31939052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiology and risk factors for invasive fungal infections during induction chemotherapy for newly diagnosed acute myeloid leukemia: A retrospective cohort study.
    Lien MY; Chou CH; Lin CC; Bai LY; Chiu CF; Yeh SP; Ho MW
    PLoS One; 2018; 13(6):e0197851. PubMed ID: 29883443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The incidence of invasive fungal infections in neutropenic patients with acute leukemia and myelodysplastic syndromes receiving primary antifungal prophylaxis with voriconazole.
    Barreto JN; Beach CL; Wolf RC; Merten JA; Tosh PK; Wilson JW; Hogan WJ; Litzow MR
    Am J Hematol; 2013 Apr; 88(4):283-8. PubMed ID: 23460251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pattern of bloodstream infections in patients with hematological malignancies in a tertiary care centre.
    Bansal S; Advani SH
    Indian J Cancer; 2014; 51(4):447-9. PubMed ID: 26842155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bacteremia during neutropenia is a predictive factor for invasive fungal infection in children.
    Sano H; Kobayashi R; Suzuki D; Kishimoto K; Yasuda K; Kobayashi K
    Pediatr Int; 2013 Apr; 55(2):145-50. PubMed ID: 23253211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Invasive fungal infections in paediatric acute myeloid leukaemia.
    Johnston DL; Lewis V; Yanofsky R; Gillmeister B; Ethier MC; Mitchell D; Cellot S; Dix D; Portwine C; Price V; Silva M; Zelcer S; Michon B; Bowes L; Stobart K; Brossard J; Beyene J; Sung L
    Mycoses; 2013 Jul; 56(4):482-7. PubMed ID: 23437849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overall survival and fungal infection-related mortality in patients with invasive fungal infection and neutropenia after myelosuppressive chemotherapy in a tertiary care centre from 1995 to 2006.
    Hahn-Ast C; Glasmacher A; Mückter S; Schmitz A; Kraemer A; Marklein G; Brossart P; von Lilienfeld-Toal M
    J Antimicrob Chemother; 2010 Apr; 65(4):761-8. PubMed ID: 20106864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequency and Determinants of Invasive Fungal Infections in Children With Solid and Hematologic Malignancies in a Nonallogeneic Stem Cell Transplantation Setting: A Narrative Review.
    Ruijters VJ; Oosterom N; Wolfs TFW; van den Heuvel-Eibrink MM; van Grotel M
    J Pediatr Hematol Oncol; 2019 Jul; 41(5):345-354. PubMed ID: 30973485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Invasive fungal infections in pediatric patients with hematologic malignancies receiving oral amphotericin B solution and early intravenous administration of fluconazole.
    Watanabe N; Matsumoto K; Kojima S; Kato K
    J Pediatr Hematol Oncol; 2011 May; 33(4):270-5. PubMed ID: 21464763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High rate of invasive fungal infections during early cycles of azacitidine for patients with acute myeloid leukemia.
    Wang ST; Chou CH; Chen TT; Lin CC; Bai LY; Yeh SP; Ho MW; Lien MY
    Front Cell Infect Microbiol; 2022; 12():1012334. PubMed ID: 36530436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical Characteristics and Risk Factors of Invasive Fungal Infections in Acute Leukemia Patients in Tropical Regions].
    Zheng WS; Guan LX; Wang SY; Hu YL; Peng B; Bo J; Wang QS; Gao XN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Feb; 30(1):99-106. PubMed ID: 35123610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of invasive fungal infections in patients with high-risk MDS and AML receiving hypomethylating agents.
    Kim GYG; Burns J; Freyer CW; Hamilton KW; Frey NV; Gill SI; Hexner EO; Luger SM; Mangan JK; Martin ME; McCurdy SR; Perl AE; Porter DL; Schuster MG; Stadtmauer EA; Loren AW
    Am J Hematol; 2020 Jul; 95(7):792-798. PubMed ID: 32242967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Invasive fungal infections in children with hematologic and malignant diseases.
    Ozsevik SN; Sensoy G; Karli A; Albayrak C; Dagdemir A; Belet N; Elli M; Fisgin T; Ozyurek E; Duru F; Albayrak D
    J Pediatr Hematol Oncol; 2015 Mar; 37(2):e69-72. PubMed ID: 25072372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breakthrough invasive fungal infection in patients with myeloid malignancy receiving posaconazole tablet prophylaxis: Clinical features, risk factors, and posaconazole profiles.
    Hong JY; Kang CI; Yang J; Ko JH; Huh K; Cho SY; Chung DR; Jung CW; Peck KR
    Med Mycol; 2023 Apr; 61(5):. PubMed ID: 37120735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of pan-fungal PCR assay and Aspergillus antigen detection in the diagnosis of invasive fungal infections in high risk paediatric cancer patients.
    El-Mahallawy HA; Shaker HH; Ali Helmy H; Mostafa T; Razak Abo-Sedah A
    Med Mycol; 2006 Dec; 44(8):733-9. PubMed ID: 17127630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.